U.S. Actinic Keratosis Treatment Market Benefits from Aging Baby Boomer Base
The U.S. actinic keratosis (AK) treatment market was valued at USD 2.32 billion in 2022 and is projected to reach USD 2.94 billion by 2030, expanding at a CAGR of 3.03% from 2024 to 2030. Market growth is driven by the increasing prevalence of actinic keratosis, heightened risk of progression to skin cancer, and the expanding geriatric population in the country. According to JAMA...
0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior